ReviewWorld journal of gastroenterology2024

Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease.

Hang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.